Half a continent away, Buckanovich was doing his own studies on the role that the same protein played in the growth of ovarian
cancer cells in his lab at the University of Michigan.
This study found that turmeric extract reduced the growth of certain types of
cancer cells in a lab setting.
They grew pancreatic
cancer cells in lab dishes and fed them both glucose and fructose.
But this humble substance has also been studied for its biological activity against more serious matters like
cancer cells in lab tests.
We investigate organoids, the latest way that scientists are growing
cancer cells in the lab to help test hundreds of cancer drugs.
Muehlenbachs said further study was limited by the patient's death and the fact that researchers have been unable to grow tapeworm
cancer cells in the lab.
Wang's team discovered that if human lung
cancer cells in a lab dish in the presence of the receptor were treated with BCX, they migrated less than untreated ones.
In a May 2014 study, Nagrath and colleagues found that highly aggressive ovarian cancer cells were glutamine - dependent and that depriving the cells of external sources of glutamine — as some experimental drugs do — was an effective way to kill late - stage ovarian
cancer cells in the lab.
They grew
the cancer cells in the lab and injected them into mice.
«Compound in magnolia may combat head and neck cancers: Honokiol, from magnolia bark, shuts down
cancer cells in lab.»
Their study, published in the ACS journal Chemical Research in Toxicology, found that triclosan, as well as another commercial substance called octylphenol, promoted the growth of human breast
cancer cells in lab dishes and breast cancer tumors in mice.
He says that the extracts from their fibroblasts do contain the sticky substance, but that in spalacids it does not seem to play a key role in the animals» natural resistance to cancer or activity against
cancer cells in the lab.
«We have shown that our molecule works on
cancer cells in the lab, but the next step is to see if it works on real tumors in animals.
«But
cancer cells in the lab don't necessarily indicate the response of human tumors,» Håkansson reminds the group.
A COMPOUND that slows the proliferation of triple - negative breast
cancer cells in lab tests could lead to the first drugs to target this aggressive type of tumour.
The team found that if they raised glutathione levels in
cancer cells in the lab, they reversed resistance to the drug erlotinib, and the treatment was once again able to kill cancer cells.
Not exact matches
This new kind of approach to fighting blood
cancers is truly personalized; immune T -
cells are extracted from patients, genetically tinkered to home
in on an destroy cancerous
cells, multiplied
in a
lab, and then jolted back into the patient's body within about two weeks.
In a lab study, an extract of the leaves stopped the growth and progression of prostate cancer cells by up to 75 % in mic
In a
lab study, an extract of the leaves stopped the growth and progression of prostate
cancer cells by up to 75 %
in mic
in mice.
In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
In 2010, researchers from the University of Michigan Comprehensive
Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
Cancer Center published a study
in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
in the journal Clinical
Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
Cancer Research showing that sulforaphane had the ability to kill breast
cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor
cancer stem
cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
in mice and
in lab cultures, and it also prevented the growth of new tumor cell
in lab cultures, and it also prevented the growth of new tumor
cells.
Researchers at Tufts Medical School noticed that
cancer cells being grown
in the
lab multiplied more quickly
in polyester test tubes than
in glass.
The
lab that I work
in is primarily interested
in understanding how and why certain
cancers are more likely to spread to the skeleton, and my personal project has focused on uncovering new mechanisms that the
cancer cells use to communicate with other
cells in the bone.
One of his professors, Dag Jenssen, persuaded Helleday to join his
lab in the Department of Genetics, Microbiology, and Toxicology at Stockholm University to investigate the importance of recombination
in somatic
cells, tumor
cells, and
cancer initiation.
By studying human
cancer cells and animal models of
cancer in the
lab, our researchers have shown that loss of PTEN leads to high levels of PI (3,4) P2, which could result
in hyperactivation of AKT.
Previous work
in Weinberg's
lab had shown that after a tumor forms
in one part of the body, some of the
cancer cells undergo EMT, Mani explains.
The NB activity
in Alberta is far ranging, with such research as self - assembled nanostructures (M. J. Brett), single -
cell cancer analysis (L. M. Pilarski), computational modeling (D. Wishart), micro-total analysis systems or
lab on a chip (D. J. Harrison),
cell identification and manipulation (K. Kaler), and microsystems and medical diagnostics (Backhouse).
Each of the four compounds was then tested
in the
lab to see how it would affect a line of prostate
cancer cells relatively sensitive to the chemotherapeutic Paclitaxel, commonly used to treat prostate
cancer patients.
It's almost impossible to culture naked mole rat
cells in the
lab, which made Andrei Seluanov and Vera Gorbunova from Rochester University, New York, wonder if this might be linked to their ability to resist
cancer.
Daniel Chen, a postdoc
in Dogic's
lab, imagines that someday the droplets could be controlled to deliver drugs or seek out
cancer cells.
In lab tests, they show that one such particle can be produced in plants and it ferries small molecules to cancer cell
In lab tests, they show that one such particle can be produced
in plants and it ferries small molecules to cancer cell
in plants and it ferries small molecules to
cancer cells.
By hitting breast
cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target
cancer cells during a transitional stage when they were most vulnerable, killing
cells and shrinking tumors
in the
lab and
in pre-clinical models.
Bloch's colleagues at the National Institute of Environmental Health Sciences tested the oils
in gene expression studies on
lab - grown human breast
cancer cells and found that they could mimic estrogens, the primary female sex hormones, and inhibit androgens, the primary male sex hormones.
Previous work
in the
lab of CU
Cancer Center investigator, Carol Sartorius, PhD, and others shows that progesterone aids the expansion of CK5 +
cells.
Lab testing showed that the plant - made virus particles, which naturally bind to receptors on
cancer cells, were taken
in by human breast
cancer cells.
However, along with this seemingly linear storyline
in which retinoids block progesterone's promotion of CK5 +
cells, previous work
in the
lab of CU
Cancer Center investigator Peter Kabos, MD, and others shows that breast
cancers treated with anti-estrogen drugs like tamoxifen or aromatase inhibitors show an increased population of CK5 +
cells — it is as if these therapies remove the roadblock of estrogen - dependent
cells, leaving CK5 +
cells to proliferate.
After the modified T
cells make many copies of themselves
in the
lab, they're unleashed
in the patient's bloodstream to find and kill
cancer cells.
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow
in Zaret's
lab, builds on a first - of - its - kind human -
cell model of pancreatic
cancer progression the
lab described
in 2013.
«As it has been shown to be selective to
cancer cells and non-toxic to normal
cells in the
lab, this peptide has the potential to be safe, but further work would be required to prove that.»
When Conklin joined his
lab, he had no experience
in his PI's core area of
cancer research, but he brought valuable expertise
in cell imaging techniques.
New findings published
in the Proceedings of the National Academy of Sciences showed
in lab studies that supplementing an epigenetic
cancer drug called decitabine with vitamin C enhanced the drug's ability to impede
cancer cell growth and trigger cellular self - destruction
in cancer cell lines.
The group looked at an oncogene, AF1q discovered
in Tse's
lab, which is expressed
in hematological
cancer cells and is known to be related to multiple myeloma.
To create the switch, biomolecular engineer Marc Ostermeier and colleagues marshaled a protein found
in high levels
in cancer cells to activate a second protein that he built
in the
lab.
So when biologists
in Catharina Svanborg's
lab saw mothers» milk kill
cancer cells, they knew they were onto something big.
From tissue and
cell samples from five glioblastoma patients, the scientists obtained 33 individual
cancer cells capable of reproduction, which grew into very different tumors
in the
lab.
Experiments showed that HIFs controlled the production of GSTO1
in breast
cancer cells when they were exposed to chemotherapy; if HIF activity was blocked
in these
lab - grown
cells, GSTO1 was not produced.
To understand how
cancer cells could have an established tolerance, Santagata and Peter Tsvetkov, a postdoctoral researcher
in the Lindquist
lab, analyzed the genes that allow
cells to survive exposure to proteasome inhibitors at toxic levels.
Until now, little was known
in preclinical models about the mechanisms that allow breast
cancer cells to leave the latent state and even less is known in patients,» explains Roger Gomis, head of the Growth Control and Cancer Metastasi
cancer cells to leave the latent state and even less is known
in patients,» explains Roger Gomis, head of the Growth Control and
Cancer Metastasi
Cancer Metastasis
Lab.
They tested these drugs one at a time for lethal interaction with 112 different tumor - suppressor gene mutations
in human
cancer cells growing
in the
lab.
Another is that the transplanted bits of tumor act nothing like
cancers in actual human brains, Fine and colleagues reported
in 2006: Real - life glioblastomas grow and spread and resist treatment because they contain what are called tumor stem
cells, but tumor stem
cells don't grow well
in the
lab, so they don't get transplanted into those mouse brains.
«This is why some
cancers can be so difficult to treat with chemotherapy, because the
cells can be
in different states — some sensitive to treatment and some resistant to treatment, all
in the same tumor,» says Sandro Santagata, a former visiting scientist
in the
lab of Whitehead Member Susan Lindquist.
As a doctoral student
in the
lab of Drs. Margaret Wheelock and Keith Johnson at the University of Toledo, Dr. Islam focused on identifying a link between cadherins (a family of
cell adhesion proteins) and tumorigenesis (start of
cancer cell formation).